Summary

Asia Pacific Companion Animal Health Market Summary

The Asia Pacific companion animal health market size was estimated at USD 4.51 billion in 2024 and is projected to reach USD 11.26 billion by 2033, growing at a CAGR of 10.73% from 2025 to 2033. The Asia Pacific companion animal health industry is growing rapidly due to rising pet ownership, increased awareness of animal welfare, and growing disposable incomes across emerging economies.

Countries like India, China, Japan, and Australia are witnessing a surge in the number of households adopting pets, especially dogs and cats, with urbanization and nuclear family structures playing a key role. As pets increasingly become viewed as family members, owners are investing more in preventive healthcare, including vaccinations, diagnostics, parasite control, and wellness products. For instance, according to a USDA Foreign Agricultural Service report, China’s total pet population reached 124.1 million in 2024, comprising 52.6 million dogs and 71.5 million cats, representing a growth of 1.6% for dogs and 2.5% for cats compared to 2023.

Simultaneously, demand for advanced veterinary care is fueling innovation, with companies introducing cutting-edge solutions such as combination parasiticides (e.g., NexGard SPECTRA) and emerging therapies like canine gene treatments for heart disease. These breakthroughs, alongside a strengthening veterinary infrastructure and an improving regulatory environment, are transforming pet healthcare into a high-growth, tech-driven sector.

Moreover, the rapid advancement and adoption of integrated diagnostic and specialized veterinary care services across the region are driving the Asia Pacific companion animal health industry significantly. As pet ownership grows across urban and semi-urban regions, there is increasing demand for comprehensive, one-stop veterinary solutions. Clinics and hospitals are responding by upgrading infrastructure and introducing in-house diagnostics such as digital imaging, blood testing, and ultrasound. This trend is evident in facilities like Soulmates Vet Hospital in Belagavi, India, which launched in April 2025 with integrated diagnostic capabilities.

Similarly, in February 2025, Veterinary Cardiologists Australia opened the country’s first dedicated veterinary cardiology hospital. This reflects a broader trend towards super-specialization in companion animal medicine and, with it, increased use of diagnostics such as echocardiography, cardiac biomarker testing, and advanced imaging. These private sector initiatives are also aligned with national priorities. These developments reflect a growing preference for accurate, timely diagnosis and treatment planning, making diagnostics a central pillar of veterinary care. Collectively, such innovations are strengthening the region’s veterinary ecosystem and driving the expansion of the companion animal health industry in Asia Pacific.

Asia Pacific Companion Animal Health Market Report Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Asia Pacific companion animal health market report based on product, animal type, and country:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Biologics
o Vaccines
o Modified/ Attenuated Live
o Inactivated (Killed)
o Other Vaccines
o Other Biologics
• Pharmaceuticals
o Parasiticides
o Anti-infectives
o Anti-inflammatory
o Analgesics
o Others
• Diagnostics
o Consumables, reagents and kits
o Instruments and devices
• Equipment & Disposables
o Critical Care Consumables
o Anesthesia Equipment
o Fluid Management Equipment
o Temperature Management Equipment
o Rescue & Resuscitation Equipment
o Research Equipment
o Patient Monitoring Equipment
• Medicinal Feed Additives
• Others
o Veterinary Telehealth
o Veterinary Software
• Animal Type Outlook (Revenue, USD Million, 2021 - 2033)
• Dogs
o Biologics
o Vaccines
o Modified/ Attenuated Live
o Inactivated (Killed)
o Other Vaccines
o Other Biologics
o Pharmaceuticals
o Parasiticides
o Ectoparasiticides
o Endoparasiticides
o Endectocides
o Anti-infectives
o Antimicrobials
o Anti-infectives except Antimicrobial
o Anti-inflammatory
o Analgesics
o Others
o Dermatology Products
o Otic Products
o Shampoo Products
o Other dermatology products
o Diagnostics
o Consumables, reagents and kits
o Instruments and devices
o Equipment & Disposables
o Critical Care Consumables
o Anesthesia Equipment
o Fluid Management Equipment
o Temperature Management Equipment
o Rescue & Resuscitation Equipment
o Research Equipment
o Patient Monitoring Equipment
o Medicinal Feed Additives
o Oral MFAs (includes chondroprotective)
o Injectable MFAs
o Others
o Veterinary Telehealth
o Veterinary Software
• Cats
o Biologics
o Vaccines
o Modified/ Attenuated Live
o Inactivated (Killed)
o Other Vaccines
o Other Biologics
o Pharmaceuticals
o Parasiticides
o Ectoparasiticides
o Endoparasiticides
o Endectocides
o Anti-infectives
o Antimicrobials
o Anti-infectives except Antimicrobial
o Anti-inflammatory
o Analgesics
o Others
o Dermatology Products
o Otic Products
o Shampoo Products
o Other dermatology products
o Diagnostics
o Consumables, reagents and kits
o Instruments and devices
o Equipment & Disposables
o Critical Care Consumables
o Anesthesia Equipment
o Fluid Management Equipment
o Temperature Management Equipment
o Rescue & Resuscitation Equipment
o Research Equipment
o Patient Monitoring Equipment
o Medicinal Feed Additives
o Oral MFAs (includes chondroprotective)
o Injectable MFAs
o Others
o Veterinary Telehealth
o Veterinary Software
• Horses
o Biologics
o Vaccines
o Modified/ Attenuated Live
o Inactivated (Killed)
o Other Vaccines
o Other Biologics
o Pharmaceuticals
o Parasiticides
o Anti-infectives
o Anti-inflammatory
o Analgesics
o Others
o Diagnostics
o Consumables, reagents and kits
o Instruments and devices
o Equipment & Disposables
o Critical Care Consumables
o Anesthesia Equipment
o Fluid Management Equipment
o Temperature Management Equipment
o Rescue & Resuscitation Equipment
o Research Equipment
o Patient Monitoring Equipment
o Medicinal Feed Additives
o Others
o Veterinary Telehealth
o Veterinary Software
• Pet Birds
o Biologics
o Vaccines
o Modified/ Attenuated Live
o Inactivated (Killed)
o Other Vaccines
o Other Biologics
o Pharmaceuticals
o Parasiticides
o Anti-infectives
o Anti-inflammatory
o Analgesics
o Others
o Diagnostics
o Consumables, reagents and kits
o Instruments and devices
o Equipment & Disposables
o Critical Care Consumables
o Anesthesia Equipment
o Fluid Management Equipment
o Temperature Management Equipment
o Rescue & Resuscitation Equipment
o Research Equipment
o Patient Monitoring Equipment
o Medicinal Feed Additives
o Others
o Veterinary Telehealth
o Veterinary Software
• Other Companion Animals
o Biologics
o Vaccines
o Modified/ Attenuated Live
o Inactivated (Killed)
o Other Vaccines
o Other Biologics
o Pharmaceuticals
o Parasiticides
o Anti-infectives
o Anti-inflammatory
o Analgesics
o Others
o Diagnostics
o Consumables, reagents and kits
o Instruments and devices
o Equipment & Disposables
o Critical Care Consumables
o Anesthesia Equipment
o Fluid Management Equipment
o Temperature Management Equipment
o Rescue & Resuscitation Equipment
o Research Equipment
o Patient Monitoring Equipment
o Medicinal Feed Additives
o Others
o Veterinary Telehealth
o Veterinary Software
• Country Outlook (Revenue, USD Million, 2021 - 2033)
• Japan
• China
• India
• Indonesia
• Thailand
• Australia
• South Korea
• Philippines
• Malaysia
• Singapore
• Vietnam